Position in ABBV
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$8,151,122
+$1,008,968 QoQ
Shares Held
32,392
-1.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,028
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Procyon Advisors, LLC holds $38,982,476 across 11 Drug Manufacturers - General names. ABBV ranks #1 (20.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
32,392 | $8,151,122 | |
| 2 | JNJ |
Johnson & Johnson
|
30,495 | $7,744,815 | |
| 3 | LLY |
ELI LILLY & Co
|
6,408 | $7,685,948 | |
| 4 | MRK |
Merck & Co., Inc.
|
50,916 | $6,542,706 | |
| 5 | AMGN |
Amgen Inc
|
6,850 | $2,480,522 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
17,103 | $2,160,793 | |
| 7 | PFE |
Pfizer Inc
|
55,347 | $1,332,755 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,718 | $963,291 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,151,122 | 32,392 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $7,142,154 | 32,839 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $7,483,504 | 32,752 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $6,326,830 | 27,325 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $4,713,263 | 25,392 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $6,738,791 | 32,163 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $4,950,899 | 27,861 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $5,459,729 | 27,647 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $4,952,468 | 28,874 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $5,112,639 | 28,076 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $4,678,234 | 30,188 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $4,637,554 | 31,112 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $3,812,993 | 28,301 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $4,748,588 | 29,796 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $4,724,345 | 29,233 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $3,348,002 | 24,946 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $4,312,372 | 28,156 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $5,484,343 | 33,831 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $4,323,728 | 31,933 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $3,198,669 | 29,653 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $3,123,845 | 27,733 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $2,068,733 | 19,116 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $2,022,777 | 18,878 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $1,560,153 | 17,812 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $1,747,604 | 17,800 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,282,887 | 16,838 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||